NCT05512806View on ClinicalTrials.gov

A Bioavailability and Food Effect Study of AZD5462 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

November 7, 2022

Study Completion Date

November 7, 2022

Conditions

Healthy Participants

Interventions

DRUG

AZD5462

Participants will receive AZD5462 orally.

Trial Locations (1)

21225

Research Site, Brooklyn

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY